Clinical Oncology Centre #1

Krasnodar 350040

0 studies enrolling now · 2 studies all time

What they study most

Estrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast Cancer, Melanoma, Melanoma (Skin), Melanoma Stage III, Melanoma Stage IV

Studies at this site

• A Study Evaluating the Efficacy and Safety of Giredestrant Compared With Physician's Choice of Endocrine Monotherapy in Participants With Previously Treated Estrogen Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer (acelERA Breast Cancer) — Running, not enrolling
• Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence — Stopped early